A detailed history of Quantinno Capital Management LP transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Quantinno Capital Management LP holds 3,273 shares of LH stock, worth $667,233. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,273
Previous 2,855 14.64%
Holding current value
$667,233
Previous $648,000 10.34%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $87,366 - $97,210
418 Added 14.64%
3,273 $715,000
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $242,763 - $279,112
1,228 Added 75.48%
2,855 $648,000
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $86,652 - $95,552
431 Added 36.04%
1,627 $327,000
Q2 2023

Aug 04, 2023

SELL
$211.93 - $241.33 $121,647 - $138,523
-574 Reduced 32.43%
1,196 $288,000
Q1 2023

May 03, 2023

SELL
$213.32 - $257.83 $1.02 Million - $1.23 Million
-4,788 Reduced 73.01%
1,770 $406,000
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $9,982 - $12,199
49 Added 0.75%
6,558 $1.54 Million
Q3 2022

Nov 07, 2022

BUY
$204.81 - $262.19 $711,919 - $911,372
3,476 Added 114.61%
6,509 $1.33 Million
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $473,272 - $614,926
2,213 Added 269.88%
3,033 $711,000
Q1 2022

May 12, 2022

SELL
$259.82 - $298.18 $539,386 - $619,021
-2,076 Reduced 71.69%
820 $216,000
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $786,553 - $909,952
2,896 New
2,896 $910,000
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $184,020 - $344,473
-1,764 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $288,378 - $306,248
1,764 New
1,764 $298,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.